Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Writing and Speaking > Writing Articles > Ezine Article Sites; Should They Allow Comments on Articles?

Tags

  • combination
  • patients
  • taking
  • developing combination
  • developing combination
  • developing combination

  • Links

  • Happiness, the Carrot
  • Jamison Set To Carry Wizards Alone With Butler And Arenas Injured
  • Answers To The Most Common Homeschooling Questions
  • Top Articles - Ezine Article Sites; Should They Allow Comments on Articles?

    Interactive-ness on Internet Sites drives traffic. Many Blogs and
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    Forums are indeed places people go to enjoy themselves in online v
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    rtual communities. Should Ezine Article Sites or online article su
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    mission sites allow comments from readers to help provide addition
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    l interactivity? What if people post negative comments?

    If so the
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    n the comments sections must be monitored taking up precious time
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    n moderation and taking time to other important endeavors too. But
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    also we must understand that indeed Controversy sells and attracts
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    something to do with the innate characteristics of the species.

    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    Inter active comments are a value added service for the reader, bu
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    for Ezine Article Sites; Should they allow comments on articles?
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    feel that when I write a politically charged or attacking article
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    and someone has a legitimate counter argument, then go for it; but
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    when the comment attacks my personal character or intelligence, w
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ll, I just find those comments unworthy and therefore prefer no co
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ments.

    Personally, I have read other articles I have liked very m
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ch and commented and those I do not like or actually know in fact
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    that the author is a moron, I simply do nothing, as if you have no
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    hing nice to say, don’t say anything. But should comments be allow
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    d at all on Online Article Submission Sites? Consider this in 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/167544/toparticles-Ezine-Article-Sites-Should-They-Allow-Comments-on-Articles.html">Ezine Article Sites; Should They Allow Comments on Articles?</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/167544/toparticles-Ezine-Article-Sites-Should-They-Allow-Comments-on-Articles.html]Ezine Article Sites; Should They Allow Comments on Articles?[/url]

    Related Articles:

    8 Strategies To Catapult Your Copywriting Skills To The Next Level

    Productive Affiliate Marketing – What You Need to Know about Affiliate Marketing

    All That You Want To Know About Coin Sorters

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com